ANDA 85684, held by Watson Labs. Promethazine Hydrochloride.
As of Nov 16, 2026, ANDA 85684 (Promethazine Hydrochloride), held by Watson Labs, was first approved by FDA on Sep 26, 1977, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 26, 1977 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Promethazine Hydrochloride25MG ยท tablet;oral | Promethazine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters